Literature DB >> 19464816

Tumor bed delineation for partial breast and breast boost radiotherapy planned in the prone position: what does MRI add to X-ray CT localization of titanium clips placed in the excision cavity wall?

Anna M Kirby1, John R Yarnold, Philip M Evans, Veronica A Morgan, Maria A Schmidt, Erica D Scurr, Nandita M desouza.   

Abstract

PURPOSE: To compare tumor bed (TB) volumes delineated using magnetic resonance imaging plus computed tomography and clips (MRCT) with those delineated using CT and clips (CT/clips) alone in postlumpectomy breast cancer patients positioned prone and to determine the value of MRCT for planning partial breast irradiation (PBI). METHODS AND MATERIALS: Thirty women with breast cancer each had 6 to 12 titanium clips secured in the excision cavity walls at lumpectomy. Patients underwent CT imaging in the prone position, followed by MRI (T(1)-weighted [standard and fat-suppressed] and T(2)-weighted sequences) in the prone position. TB volumes were delineated separately on CT and on fused MRCT datasets. Clinical target volumes (CTV) (where CTV = TB + 15 mm) and planning target volumes (PTV) (where PTV = CTV + 10 mm) were generated. Conformity indices between CT- and MRCT-defined target volumes were calculated (ratio of the volume of agreement to total delineated volume). Discordance was expressed as a geographical miss index (GMI) (where the GMI = the fraction of total delineated volume not defined by CT) and a normal tissue index (the fraction of total delineated volume designated as normal tissue on MRCT). PBI dose distributions were generated to cover CT-defined CTV (CTV(CT)) with >or=95% of the reference dose. The percentage of MRCT-defined CTV (CTV(MRCT)) receiving >or=95% of the reference dose was measured.
RESULTS: Mean conformity indices were 0.54 (TB), 0.84 (CTV), and 0.89 (PTV). For TB volumes, the GMI was 0.37, and the NTI was 0.09. Median percentage volume coverage of CTV(CT) was 97.1% (range, 95.3%-100.0%) and of CTV(MRCT) was 96.5% (range, 89.0%-100.0%).
CONCLUSIONS: Addition of MR to CT/clip data generated TB volumes that were discordant with those based on CT/clips alone. However, clinically satisfactory coverage of CTV(MRCT) by CTV(CT)-based tangential PBI fields provides support for CT/clip-based TB delineation remaining the method of choice for PBI/breast boost radiotherapy planned using tangential fields.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464816     DOI: 10.1016/j.ijrobp.2009.02.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Impact of a Novel Bioabsorbable Implant on Radiation Treatment Planning for Breast Cancer.

Authors:  Michael J Cross; Gail S Lebovic; Joseph Ross; Scott Jones; Arnold Smith; Steven Harms
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

2.  Image-Based Treatment Planning of the Post-Lumpectomy Breast Utilizing CT and 3TMRI.

Authors:  Geraldine Jacobson; Gideon Zamba; Vicki Betts; M Muruganandham; Joni Buechler-Price
Journal:  Int J Breast Cancer       Date:  2011-04-06

3.  Can initial diagnostic PET-CT aid to localize tumor bed in breast cancer radiotherapy: feasibility study using deformable image registration.

Authors:  Oyeon Cho; Mison Chun; Young-Taek Oh; Mi-Hwa Kim; Hae-Jin Park; Jae-Sung Heo; O Kyu Noh
Journal:  Radiat Oncol       Date:  2013-07-03       Impact factor: 3.481

4.  Post-lumpectomy CT-guided tumor bed delineation for breast boost and partial breast irradiation: Can additional pre- and postoperative imaging reduce interobserver variability?

Authors:  Mariska D DEN Hartogh; Marielle E P Philippens; Iris E VAN Dam; Catharina E Kleynen; Robbert J H A Tersteeg; Alexis N T J Kotte; Marco VAN Vulpen; Bram VAN Asselen; Desirée H J G VAN DEN Bongard
Journal:  Oncol Lett       Date:  2015-09-14       Impact factor: 2.967

5.  MRI Reduces Variation of Contouring for Boost Clinical Target Volume in Breast Cancer Patients Without Surgical Clips in the Tumour Bed.

Authors:  Noora Al-Hammadi; Palmira Caparrotti; Saju Divakar; Mohamed Riyas; Suparna Halsnad Chandramouli; Rabih Hammoud; Jillian Hayes; Maeve Mc Garry; Satheesh Prasad Paloor; Primoz Petric
Journal:  Radiol Oncol       Date:  2017-03-17       Impact factor: 2.991

6.  3D-conformal accelerated partial breast irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity.

Authors:  Maia Dzhugashvili; Elodie Tournay; Charlotte Pichenot; Ariane Dunant; Eduardo Pessoa; Adel Khallel; Sébastien Gouy; Catherine Uzan; Jean-Rémy Garbay; Françoise Rimareix; Marc Spielmann; Philippe Vielh; Hugo Marsiglia; Céline Bourgier
Journal:  Radiat Oncol       Date:  2009-12-31       Impact factor: 3.481

7.  The Impact of Different Simulation Modalities on Target Volume Delineation in Breast-Conserving Radiotherapy.

Authors:  Meng Jin; Xia Liu; Jiabin Ma; Xiansong Sun; Hongnan Zhen; Jing Shen; Zhikai Liu; Xin Lian; Zheng Miao; Ke Hu; Xiaorong Hou; Fuquan Zhang
Journal:  Cancer Manag Res       Date:  2021-07-12       Impact factor: 3.989

8.  Inter-observer variations of the tumor bed delineation for patients after breast conserving surgery in preoperative magnetic resonance and computed tomography scan fusion.

Authors:  Jie Jiang; Jinhu Chen; Wanhu Li; Yongqing Li; Yiru Chen; Zicheng Zhang; Chengxin Liu; Dan Han; Hongfu Sun; Baosheng Li; Wei Huang
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

Review 9.  The potential for an enhanced role for MRI in radiation-therapy treatment planning.

Authors:  P Metcalfe; G P Liney; L Holloway; A Walker; M Barton; G P Delaney; S Vinod; W Tome
Journal:  Technol Cancer Res Treat       Date:  2013-04-24

Review 10.  Optimizing MR-Guided Radiotherapy for Breast Cancer Patients.

Authors:  Maureen L Groot Koerkamp; Jeanine E Vasmel; Nicola S Russell; Simona F Shaitelman; Carmel N Anandadas; Adam Currey; Danny Vesprini; Brian M Keller; Chiara De-Colle; Kathy Han; Lior Z Braunstein; Faisal Mahmood; Ebbe L Lorenzen; Marielle E P Philippens; Helena M Verkooijen; Jan J W Lagendijk; Antonetta C Houweling; H J G Desiree van den Bongard; Anna M Kirby
Journal:  Front Oncol       Date:  2020-07-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.